Acorah Software Products - Accounts Production 16.0.110 false true false true No description of principal activity 13 March 2023 31 March 2024 31 March 2024 14725009 Mrs Pina Tauinaola Coombes iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14725009 2023-03-12 14725009 2024-03-31 14725009 2023-03-13 2024-03-31 14725009 frs-core:CurrentFinancialInstruments 2024-03-31 14725009 frs-bus:PrivateLimitedCompanyLtd 2023-03-13 2024-03-31 14725009 frs-bus:FilletedAccounts 2023-03-13 2024-03-31 14725009 frs-bus:Micro-entities 2023-03-13 2024-03-31 14725009 frs-bus:AuditExempt-NoAccountantsReport 2023-03-13 2024-03-31 14725009 frs-bus:Director1 2023-03-13 2024-03-31
Registered number: 14725009
AVRO Health LTD
Unaudited Financial Statements
For the Period 13 March 2023 to 31 March 2024
Berkshire Accountants Limited
Chartered Certified Accountants & Registered Auditors
50A London Street
Reading
RG1 4SQ
Balance Sheet
Registered number: 14725009
31 March 2024
£
Current assets 1,448
Creditors: Amounts Falling Due Within One Year (4,848 )
NET CURRENT LIABILITIES (3,400 )
TOTAL ASSETS LESS CURRENT LIABILITIES (3,400 )
Accruals and deferred income (300 )
NET LIABILITIES (3,700 )
CAPITAL AND RESERVES (3,700 )

Notes

1. General Information
AVRO Health LTD is a private company, limited by shares, incorporated in England & Wales, registered number 14725009 . The registered office is 50A London Street, Reading, RG1 4SQ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Pina Tauinaola Coombes
Director
15 November 2024